{"symbol":"DHR","fiscalQuarter":"Q1-2012","reportDate":"2012-04-19","reportTime":"BMO","status":"reported","company":{"name":"Danaher Corporation","sector":"Health Care","industry":"Life Sciences Tools & Services"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/DHR/earnings/Q1-2012","postBrief":{"headline":"Danaher Corporation Beats on EPS, Stock Down 3.09%","keyNumbers":[{"metric":"EPS","actual":"$0.73","expected":"N/A","surprise":"+3.84%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Unknown","keyQuotes":[],"summary":"No transcript is on record, and the analysis is based solely on numerical results."},"guidanceChanges":{"summary":"No forward guidance data is available.","changes":[]},"whatItMeans":"Danaher Corporation reported an EPS of $0.73, exceeding expectations slightly. However, the stock fell by 3.09% in reaction to the earnings report, indicating that investors may have been looking for stronger overall performance or additional guidance. The lack of revenue data and management commentary may have contributed to investor uncertainty.","metaDescription":"Danaher Corporation (DHR) Q1 2012 earnings: EPS beat by 3.84%. Stock down 3.09%. Full breakdown."}}